S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Is This The End of Capitalism? (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
The Next Big Crisis Is Here (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Is This The End of Capitalism? (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
The Next Big Crisis Is Here (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Is This The End of Capitalism? (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
The Next Big Crisis Is Here (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Is This The End of Capitalism? (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
The Next Big Crisis Is Here (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
NYSEAMERICAN:INFU

InfuSystem - INFU Stock Forecast, Price & News

$9.76
-0.01 (-0.10%)
(As of 01/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$9.67
$9.95
50-Day Range
$7.56
$10.05
52-Week Range
$6.10
$15.49
Volume
16,168 shs
Average Volume
48,646 shs
Market Capitalization
$201.64 million
P/E Ratio
976.98
Dividend Yield
N/A
Price Target
$22.00

InfuSystem MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
125.4% Upside
$22.00 Price Target
Short Interest
Healthy
0.53% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.20
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$1.05 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.78 out of 5 stars


INFU stock logo

About InfuSystem (NYSEAMERICAN:INFU) Stock

InfuSystem Holdings, Inc. engages in the provision of healthcare services. It operates through the Integrated Therapy Services and Durable Medical Equipment segments. The Integrated Therapy Services segment focuses on providing electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics, and hospital outpatient oncology clinics. The Durable Medical Equipment segment is involved in the rental, sale or leasing of pole-mounted and ambulatory infusion pumps to oncology practices, hospitals, and other clinical settings. The company was founded in August 2005 and headquartered in Rochester Hills, MI.

Receive INFU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

INFU Stock News Headlines

The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
InfuSystem Reports Third Quarter 2022 Financial Results
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
INFU InfuSystem Holdings, Inc.
Infusystem Hldgs, Inc. Reports In-Line Q2 EPS
InfuSystem Q2 2022 Earnings Preview
See More Headlines
Receive INFU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

INFU Company Calendar

Last Earnings
11/08/2022
Today
1/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:INFU
Employees
394
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$22.00
High Stock Price Forecast
$22.00
Low Stock Price Forecast
$22.00
Forecasted Upside/Downside
+125.4%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$1.42 million
Pretax Margin
0.63%

Debt

Sales & Book Value

Annual Sales
$102.38 million
Cash Flow
$0.78 per share
Book Value
$2.34 per share

Miscellaneous

Free Float
16,587,000
Market Cap
$201.64 million
Optionable
Not Optionable
Beta
1.15

Key Executives

  • Richard A. Dilorio
    Chief Executive Officer & Director
  • Carrie A. Lachance
    President, Chief Operating Officer & Director
  • Barry G. Steele
    Chief Financial Officer & Executive Vice President
  • Addam Chupa
    Chief Information Officer & Executive VP
  • Jeanie Latz
    Secretary













INFU Stock - Frequently Asked Questions

What is InfuSystem's stock price forecast for 2023?

0 Wall Street analysts have issued 12 month price targets for InfuSystem's shares. Their INFU share price forecasts range from $22.00 to $22.00. On average, they anticipate the company's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 125.4% from the stock's current price.
View analysts price targets for INFU
or view top-rated stocks among Wall Street analysts.

How have INFU shares performed in 2023?

InfuSystem's stock was trading at $9.30 on January 1st, 2023. Since then, INFU stock has increased by 4.9% and is now trading at $9.76.
View the best growth stocks for 2023 here
.

Are investors shorting InfuSystem?

InfuSystem saw a decrease in short interest during the month of December. As of December 30th, there was short interest totaling 99,700 shares, a decrease of 12.1% from the December 15th total of 113,400 shares. Based on an average trading volume of 37,100 shares, the short-interest ratio is currently 2.7 days. Currently, 0.6% of the shares of the company are sold short.
View InfuSystem's Short Interest
.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) released its quarterly earnings results on Tuesday, November, 8th. The medical instruments supplier reported $0.02 earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $27.28 million for the quarter. InfuSystem had a net margin of 0.28% and a trailing twelve-month return on equity of 0.63%.

What guidance has InfuSystem issued on next quarter's earnings?

InfuSystem issued an update on its FY 2022 earnings guidance on Thursday, December, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $112.00 million-$112.00 million, compared to the consensus revenue estimate of $112.67 million.

What other stocks do shareholders of InfuSystem own?
What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

Who are InfuSystem's major shareholders?

InfuSystem's stock is owned by many different institutional and retail investors. Top institutional investors include Greenwood Capital Associates LLC (0.51%), Riverwater Partners LLC (0.25%), ARS Investment Partners LLC (0.19%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Barry G Steele, Blueline Capital Partners Ii,, Carrie Lachance, Christopher R Sansone, Gregg Owen Lehman, Jeannine Sheehan, Kevin Whitman, Meridian Ohc Partners, Lp, Paul Andrew Gendron, Richard Dilorio, Scott Shuda and Thomas Mark Ruiz.
View institutional ownership trends
.

How do I buy shares of InfuSystem?

Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InfuSystem's stock price today?

One share of INFU stock can currently be purchased for approximately $9.76.

How much money does InfuSystem make?

InfuSystem (NYSEAMERICAN:INFU) has a market capitalization of $201.64 million and generates $102.38 million in revenue each year. The medical instruments supplier earns $1.42 million in net income (profit) each year or $0.01 on an earnings per share basis.

How many employees does InfuSystem have?

The company employs 394 workers across the globe.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The official website for the company is ir.infusystem.com. The medical instruments supplier can be reached via phone at (124) 291-1210 or via fax at 800-455-4338.

This page (NYSEAMERICAN:INFU) was last updated on 1/31/2023 by MarketBeat.com Staff